Schonfeld Strategic Advisors’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-15,927
| Closed | -$28.2K | – | 2062 |
|
|
2024
Q2 | $28.2K | Sell |
15,927
-1,213,361
| -99% | -$2.15M | ﹤0.01% | 1845 |
|
|
2024
Q1 | $3.33M | Buy |
1,229,288
+1,038,004
| +543% | +$2.81M | 0.02% | 659 |
|
|
2023
Q4 | $423K | Buy |
191,284
+48,284
| +34% | +$107K | ﹤0.01% | 1261 |
|
|
2023
Q3 | $415K | Buy |
+143,000
| New | +$415K | ﹤0.01% | 1126 |
|
|
2022
Q3 | – | Sell |
-24,530
| Closed | -$39K | – | 2977 |
|
|
2022
Q2 | $39K | Buy |
+24,530
| New | +$39K | ﹤0.01% | 2176 |
|
|
2020
Q4 | – | Sell |
-210,600
| Closed | -$1.56M | – | 1678 |
|
|
2020
Q3 | $1.56M | Buy |
+210,600
| New | +$1.56M | 0.03% | 546 |
|
|
2020
Q2 | – | Sell |
-26,800
| Closed | -$68K | – | 1357 |
|
|
2020
Q1 | $68K | Sell |
26,800
-95,000
| -78% | -$241K | ﹤0.01% | 1035 |
|
|
2019
Q4 | $424K | Sell |
121,800
-213,400
| -64% | -$743K | 0.01% | 819 |
|
|
2019
Q3 | $1.55M | Sell |
335,200
-261,500
| -44% | -$1.21M | 0.05% | 372 |
|
|
2019
Q2 | $7.35M | Sell |
596,700
-555,900
| -48% | -$6.85M | 0.26% | 94 |
|
|
2019
Q1 | $15.3M | Buy |
1,152,600
+196,900
| +21% | +$2.62M | 0.53% | 32 |
|
|
2018
Q4 | $8.24M | Buy |
955,700
+530,300
| +125% | +$4.57M | 0.32% | 76 |
|
|
2018
Q3 | $3.19M | Buy |
425,400
+125,400
| +42% | +$939K | 0.14% | 203 |
|
|
2018
Q2 | $1.79M | Buy |
300,000
+150,494
| +101% | +$897K | 0.1% | 288 |
|
|
2018
Q1 | $873K | Buy |
+149,506
| New | +$873K | 0.07% | 356 |
|